OABI
NASDAQ · Life Sciences Tools & Services
Omniab Inc
$2.18
-0.01 (-0.46%)
Analyst Consensus
Strong Buy
13
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+151.4% upside
Low Target
$3.95
Average Target
$5.48
High Target
$7.31
Current Price
$2.18
Current
$2.18
$2.18
Target
$5.48
$5.48
$3.95
$5.48 avg
$7.31
Scenario Analysis
Bear Case
$3.95
81.2%
Low target
Base Case
$5.48
+151.4%
Avg target
Bull Case
$7.31
+235.3%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$2.30
-5.0% from high
52-Week Low
$1.22
+78.7% from low
Target vs 52W High
$5.48
+138.8% vs high
Peer Consensus — Life Sciences Tools & Services
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| TMO | Strong Buy | 34 | 88% | $369.21 | -17.3% |
| DHR | Strong Buy | 30 | 87% | $158.11 | -5.3% |
| WAT | Buy | 28 | 57% | $189.60 | -43.1% |
| A | Strong Buy | 28 | 79% | $64.69 | -41.5% |
| IQV | Strong Buy | 31 | 87% | $82.96 | -52.1% |
| ILMN | Hold | 28 | 54% | $169.36 | +19.5% |
| WST | Strong Buy | 23 | 78% | $136.24 | -55.0% |
| MTD | Hold | 21 | 48% | $170.43 | -84.2% |